EKSO
EKSO BIONICS HOLDINGS, INC.
NASDAQ · Healthcare · Medical - Instruments & Supplies · US
$15.90
−9.86%Sep 16, 2026, 21:13 UTC
ChronoScale Holdings Corp amended its Secured Promissory Note and Security Agreement with B. Riley Commercial Capital, LLC, extending the maturity date to November 12, 2026 and designating the sale of guarantor Ekso Bionics, Inc. as a Permitted Disposition.
Aug 18, 2026, 00:00 UTC
ChronoScale Holdings Corp appointed Jerome Wong as Chief Financial Officer, effective August 16, 2026, with an annual base salary of $400,000, a bonus target of 60% of base salary, and a grant of 300,000 restricted stock units vesting over time.
May 4, 2026, 00:00 UTC
Ekso Bionics Holdings, Inc. signed a PIPE investment agreement to issue 1,311,407 shares of its common stock at $12.01 per share to Applied Digital Corporation, raising approximately $15.75 million, with closing conditioned on the effectiveness of its amended articles and the closing of its previously announced business combination.